Fenwick & West represented Royalty Pharma, and Orrick Herrington & Sutcliffe represented Ferring Pharmaceuticals in the deal.Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals announced that…
Royalty Pharma $500 Million Royalty Agreement with Ferring Pharmaceuticals
